2016. ISPOR Annual International Meeting – Anti-CCP2 Quartile Comparison of the Cost per Response for Abatacept Compared to Adalimumab Based on Sample in the US

Walsem Av, Patel C, Johnston S, Alemao E, Gaultney J. Anti-CCP2 Quartile Comparison of the Cost per Response for Abatacept Compared to Adalimumab Based on Sample in the US. Value Health. 2016 May;19(3):A233. Presented at: ISPOR 21st Annual International Meeting; May 24, 2016; Washington DC, USA.